Gate2Brain in Transfiere – European Forum for Science, Technology & Innovation

Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.Transfiere

Next Wednesday, February 16, Gate2Brain will be in Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga.

Our CEO, Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the Boosting Zone for being one of the companies that have been awarded the NEOTEC 2021 program of the CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.

/by
You might also like
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck
G2B receives funding to accelerate its transfer to the market and society
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness Series
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer
Gate2Brain attends the 1st edition of the, Fundació Bosch i Gimpera, University of Barcelona spin-offs gathering “Cockroaches vs Unicorns”universitat de barcelonaGate2Brain attends the 1st edition of the University of Barcelona spin-offs “Cockroaches vs Unicorns”
Innovation & Scalability for the new generationsInnovation & Scalability for the new generations
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

How to transport drugs to the brain to treat pathologies?¿Cómo transportar fármacos al cerebro para tratar patologías?La Vanguardiadoctorat industrialAn industrial doctorate is looking to transport drugs to the brain to treat...